ABT vs OLN · P/E 25, rev $44.33B vs rev $6.54B
Abbott Laboratories (ABT) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OLN currently screens at market cap $2.62B.
Not investment advice. Open the ABT and OLN stock pages for the full models.
Not investment advice.